CClinicalTrials.gg
CompletedNCT05737992Updated Feb 24, 2023

The Effect of Exercise in Water on Functional Fitness in People With Parkinson's Disease

An interventional study of Exercise in water in Parkinson, Parkinson Disease and Neurologic Disorder, sponsored by Pardis Specialized Wellness Institute. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-02-24.

Sponsored by Pardis Specialized Wellness Institute · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Apr 2022, registered Feb 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
45 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial study is to learn about the effect of aquatic exercise in parkinson's patients. The main questions it aims to answer are:

  • What is the effect of exercise in water on balance in parkinson's patients?
  • What is the effect of exercise in water on muscle strength in parkinson's patients?
  • What is the effect of exercise in water on flexibility in parkinson's patients? Parkinson's patients in this study will do some functional tests. One group of them will do exercises in water 3 times weekly for 8 weeks.
Read the detailed description

Parkinson's disease (PD) is a progressive, neurodegenerative movement disorder characterised by the motor symptoms bradykinesia, tremor, rigidity, and postural instability. These are commonly associated with non-motor disturbances, neurobehavioural symptoms and reduced quality of life.

Exercise is currently recommended as an additional strategy to manage PD-induced disability and is a key component of rehabilitation programs for people with PD.

Aquatic exercise is another form of non-conventional exercise that has been growing in popularity in the context of neurorehabilitation.16 The aquatic setting offers specific mechanical advantages due to the hydrostatic and hydrodynamic principles of buoyancy, viscosity and drag.

Due to its ability to enhance functional mobility whilst also being enjoyable,aquatic exercise has become a very popular form of physical training in the management of neurodegenerative disorders.

Recent studies suggest that high-intensity interval training (HIIT) is promising for promoting neuroplasticity in human PD, with short training time and reduced burden. Biomarkers for neuroplasticity such as brain-derived neurotrophic factor (BDNF) and neurodegeneration (including neurofilament light chain ((NfL) and α-synuclein) may play a role, but their response to HIIT is not well-investigated.

The aims of this study are to investigate the effects of HIIT exercises in water on balance, muscle strength, flexibility and gait speed in PD patients.

02

Conditions studied

  • Parkinson
  • Parkinson Disease
  • Neurologic Disorder

Keywords

  • Parkinson Disease
  • Aqua Therapy
  • Balance
  • Neurological Disorders
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,081 are open to participants now.

This study's enrollment of 42 is close to the median of 40 across 3,293 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Pardis Specialized Wellness Institute is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • clinical diagnosis of idiopathic PD, from mild to moderate stages (severity from 1 to 4), according to the original version of the Hoehn \& Yahr scale (HY)17, assessed by the neurologist
  • Having medical certificate for performing physical activities and attending heated pools

Exclusion criteria

Exclusion Criteria:

  • Having another neurological pathology
  • Having limiting orthopedic or heart associated conditions
  • changing physical activities or L-dopa-based drug intake parameters
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Exercise group

    Patients in the intervention group will do high intensity interval training (HIIT) in water. In this study, HIIT training will be short intervals (30 seconds) of movements and 15 seconds of rest.Exercises will be done in a floating position in the deep part. The intervention will be done 3 sessions weekly. The length will be 8 weeks.

    Other: Exercise in water

  • No intervention
    Control group

    The patients will continue their usual medication and their usual physical activity.

Interventions

  • OtherExercise in water

    Participants will do some exercises in water for 30-60 minutes. Exercises will be performed at a moderate exercise intensity (12-14 on the Borg Rate of Perceived (RPE) Scale). All protocols are tailor-made based on each individual's needs and physical abilities.

06

What researchers measure

Primary outcomes

  1. Rate of changes of Balance

    Balance will be assessed by Berg Balance Scale test

    Time frame: Pre test and posttest (after 8 weeks)

  2. Rate of changes of Flexibility

    Balance will be assessed by Sit \& Reach test

    Time frame: Pre test and posttest (after 8 weeks)

  3. Rate of changes of Muscle Strength

    Balance will be assessed by 30 s Sit to Stand test and Arm Curl test

    Time frame: Pre test and posttest (after 8 weeks)

  4. Rate of changes of Gait Speed

    Balance will be assessed by 4-meters gait speed test

    Time frame: Pre test and posttest (after 8 weeks)

07

Study locations

1 site
  • Pardis specialized wellness institute
    Isfahan, Iran, Islamic Republic of
08

References and documents

Publications

  • Methajarunon P, Eitivipart C, Diver CJ, Foongchomcheay A. Systematic review of published studies on aquatic exercise for balance in patients with multiple sclerosis, Parkinson's disease, and hemiplegia. Hong Kong Physiother J. 2016 Jul 7;35:12-20. doi: 10.1016/j.hkpj.2016.03.002. eCollection 2016 Dec. PubMed 30931029 ↗
  • Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001 Oct 23;57(8):1497-9. doi: 10.1212/wnl.57.8.1497. PubMed 11673599 ↗
  • Cugusi L, Cadeddu C, Nocco S, Orru F, Bandino S, Deidda M, Caria A, Bassareo PP, Piras A, Cabras S, Mercuro G. Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus. PM R. 2015 Feb;7(2):141-8; quiz 148. doi: 10.1016/j.pmrj.2014.09.004. Epub 2014 Sep 10. PubMed 25217820 ↗
  • Jimenez-Maldonado A, Renteria I, Garcia-Suarez PC, Moncada-Jimenez J, Freire-Royes LF. The Impact of High-Intensity Interval Training on Brain Derived Neurotrophic Factor in Brain: A Mini-Review. Front Neurosci. 2018 Nov 14;12:839. doi: 10.3389/fnins.2018.00839. eCollection 2018. PubMed 30487731 ↗
  • Hirsch MA, van Wegen EEH, Newman MA, Heyn PC. Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson's disease: a systematic review and meta-analysis. Transl Neurodegener. 2018 Mar 20;7:7. doi: 10.1186/s40035-018-0112-1. eCollection 2018. PubMed 29568518 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in the published article, after deidentification are to be shared.

Supporting information: Study protocol, Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05737992
Lead sponsor
Pardis Specialized Wellness Institute
Responsible party
Sponsor
First posted
Feb 21, 2023
Start date
Apr 10, 2022
Primary completion
Jun 27, 2022
Completion
Jul 5, 2022
Last update
Feb 24, 2023

Study contacts

MohammadAli Tabibi
study director · Head of Department

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion